If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in EuropeScemblix ...
When oral medicines for Chronic Myeloid Leukemia (CML) first became available, they dramatically changed what it meant to ...
A Charlotte-based library services company will close its doors next year. Baker & Taylor will shutter its headquarters off ...
Cycle Pharmaceuticals announces the launch of PHYRAGO, its first oncology product in the US. PHYRAGO is launched in ...
The fourth-ranked Hawks erased a 7-point fourth quarter deficit to stun CM on a 23-yard field goal from junior Zander ...
Markets regulator Sebi on Friday proposed measures to make it easier for investors to dematerialise physical shares and ...
CML Microsystems ( ($GB:CML) ) has issued an announcement. CML Microsystems has announced the issuance of new ordinary shares to Non-Executive ...
After Novartis (NVS) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive ...
CML Microsystems revealed on Wednesday that non-executive director Nathan Zommer had acquired 559,134 ordinary shares in the ...
The FDA has issued a complete response letter (CRL) to a new drug application (NDA) for Dasynoc for the treatment of chronic ...
A CML diagnosis, often striking young Indian adults, is now more manageable. This guide emphasizes empowering patients by ...
Markets regulator Sebi on Friday proposed measures to make it easier for investors to dematerialise physical shares and ...